Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.

NCT00452842 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00452842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00452842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
October 31, 2007
Completion date
Not reported
Enrollment
26,784
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, cerebrovascular disorders